Delivery Order SPE2DB22D2206-SPE2DB25FJA60
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,414.08 on July 24, 2025, for the supply of Sevoflurane inhalation liquid in 250ml quantities. The contract is a firm fixed price delivery order with an ultimate completion date of July 25, 2025, and is funded by the Defense Logistics Agency's Medical Supply Chain division. This award was made through open competition with no set-aside designation,...
- AmerisourceBergen Drug Corp was awarded a delivery order on August 8, 2025, valued at $1,414.08 for the supply of Sevoflurane Inhalation Liquid in 250ml quantities. This contract represents a firm fixed-price delivery order under a non-competitive set-aside arrangement, with an ultimate completion date of August 11, 2025. The contract is funded through the Defense Logistics Agency's Medical Supply Chain and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Sevoflurane Inhalation Liquid in 250ML units. This is a firm fixed-price delivery order with a ceiling value of $2,356.80 and an ultimate completion date of August 15, 2025. The award was made without set-aside designation through competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,525.98 firm fixed-price contract is for the delivery of 250 ml bottles of the anesthetic drug Sevoflurane Inhalation Liquid. The contract has a completion date of July 2, 2025 and does not utilize a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Sevoflurane Inhalation Liquid 250ml. The $3,644.96 firm fixed-price delivery order was awarded on April 18, 2024, with an ultimate completion date of April 19, 2024. The contract was not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,070.40 firm fixed-price delivery order is for 250 ml bottles of Sevoflurane inhalation liquid, a commonly used anesthetic. The contract has a completion date of February 10, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Sevoflurane Inhalation Liquid 250ML, a medical product used in healthcare settings. The contract has a firm fixed price of $2,356.80 and a completion date of May 14, 2025. AmerisourceBergen Drug Corp is the prime contractor, and the contract is not set aside for a specific...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of sevoflurane inhalation liquid in 250 mL containers. The contract has a ceiling value of $1,787.38 and an ultimate completion date of April 16, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense...
- This is a $1,123.26 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 250 ml bottles of the inhalation drug Sevoflurane. The order has a completion date of May 20, 2025. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of sevoflurane inhalation liquid. The $7,039.85 order has a completion date of January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order and does not have any major subcontractors. This order is part of a larger indefinite delivery contract (IDC) awarded by DLA...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJA60Delivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 23, 2025, for the supply of Sevoflurane Inhalation Liquid in 250ML units, with a ceiling value of $9,066.12 and a firm fixed-price contract type. The delivery order is not set-aside and will be performed at the contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date of July 24, 2025. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. Sevoflurane is a volatile anesthetic agent commonly used in surgical and medical procedures across military and federal healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor headquartered in Pennsylvania, has demonstrated consistent capability in fulfilling diverse pharmaceutical supply needs through competitively awarded contracts with the DLA. The company's extensive federal contract portfolio includes delivery of specialty medications, generic drugs, vaccines, and medical supplies across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.1k | 7/23/25 |